The Epinex Solution

A new strategy for diabetes monitoring is working! Monthly consultation with a pharmacist or diabetes educator improves health and reduces medical costs. The monthly Epinex G1A™ test will provide diabetics and their caregivers with the information they need to empower better diabetes care.

The Asheville Project and the Diabetes Ten City Challenge have proven that a program of monthly consultation for diabetics improves health, increases productivity, and pays for itself with reductions in both short- and long-term healthcare costs. Patient empowerment is the key to successful self-management missing from the standard method of diabetes control.

But there is still a critical information gap for diabetics to get the feedback they need to maintain control over their long-term health. They need to know whether they are keeping the potential damage caused by glycation in check. Daily blood glucose testing cannot give them this information. A convenient, easy to use and inexpensive monthly rapid test for glycation will be the perfect complement to the new, superior paradigm of diabetes care that has recently proven itself.

The Epinex G1A™ Test is the solution to empower better diabetes care

The G1A™ test measures Glycated Albumin, an ideal marker for short-term glycation

• Albumin replaces itself in the blood every 2-3 weeks
• Directly measures protein damage that leads to diabetes complications
• 25 years research shows advantages of Glycated Albumin monitoring
• Widely supported by scientific literature and endocrinologists

The G1A™ test is the only rapid test for measuring Glycated Albumin